The 14th International Conference on Human Retrovirology: HTLV and related retroviruses (July 1–4, 2009; Salvador, Brazil)

doi:10.1186/1742-4690-6-77

Retrovirology

Volume 6

Viewing options:

Abstract
Full text
PDF (1.2MB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Willems L

on PubMed

Willems L
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Commentary

The 14th International Conference on Human Retrovirology: HTLV and related retroviruses (July 1–4, 2009; Salvador, Brazil)

Luc Willems

Cellular and Molecular Biology, Agro-Bio Tech (FUSAG), Gembloux, Belgium and Interdisciplinary Cluster for Applied Genoproteomics (GIGA), University of Liège (ULg), Belgium

author email corresponding author email

Retrovirology 2009, 6:77doi:10.1186/1742-4690-6-77


Published:	17 August 2009

Abstract

The "14th International Conference on Human Retrovirology: HTLV and Related Retroviruses" was held in Salvador, Bahia, from July 1^stto July 4^th2009. The aim of this biennial meeting is to promote discussion and share new findings between researchers and clinicians for the benefit of patients infected by human T-lymphotropic virus (HTLV). HTLV infects approximately 15–20 million individuals worldwide and causes a broad spectrum of diseases including neurodegeneration and leukemia. The scientific program included a breadth of HTLV research topics: epidemiology, host immune response, basic mechanisms of protein function, virology, pathogenesis, clinical aspects and treatment. Exciting new findings were presented in these different fields, and the new advances have led to novel clinical trials. Here, highlights from this conference are summarized.